Noninvasive molecular imaging using anti-Trop-2 aptamer for targeted therapy of small cell lung cancer
Abstract Recent advancements in antibody-drug conjugates (ADCs) targeting trophoblast surface cell antigen 2 (Trop-2) have brought important progress in the field of targeted therapy. This progress also holds promise for the treatment of small cell lung cancer (SCLC) as anti-Trop-2 therapy appears t...
Saved in:
| Main Authors: | Yamei Chen, Xuwei Liu, Yang Sun, Keying Liu, Ding Ding, Shaoli Song, Weihong Tan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-025-03184-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The tricky effects of TROP2 in lung cancer: from clinical practice back to fundamental investigations
by: Renwang Liu, et al.
Published: (2025-08-01) -
Progress in Aptamer Research and Future Applications
by: Song Liu, et al.
Published: (2025-07-01) -
Progress of Clinical Research on Trop2 in Solid Tumors
by: Ying ZHANG, et al.
Published: (2025-01-01) -
Evaluation of Trop 2 expression in thyroid lesions
by: Vani D, et al.
Published: (2025-03-01) -
Safety profile of sacituzumab govitecan in patients with breast cancer: A systematic review and meta-analysis
by: Maria Inez Dacoregio, et al.
Published: (2025-02-01)